Bilirubin

Bilirubin CAS: 635-65-4 MDL: MFCD00005499

SDS

Size: 1 g, 5g, 10g, 25g and larger sizes available, kilogram and multikilogram quantities available

Molecular Formula: C33H36N4O6

MW: 584.66

CAS: 635-65-4

Storage: Store at 0 – 4 degrees Celsius, protect from light

Synonyms: Bilirubin, NSC-26685, CHEMBL501680, (4Z,15Z)-Bilirubin IXa;  (Z,Z)-Bilirubin;  (Z,Z)-Bilirubin IXa;  1,10,19,22,23,24-hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-Biline-8,12-dipropionic acid, 1,3,6,7-Tetramethyl-4,5-dicarboxyethyl-2,8-divinyl-(b-13)-dihydrobilenone;  21H-Biline-8,12-dipropanoic acid, 2,17-diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-;  3-{2-({3-(2-Carboxyethyl)-4-methyl-5-[(Z)-(3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-yliden)methyl]-1H-pyrrol-2-yl}methyl)-4-methyl-5-[(Z)-(4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-yliden)methyl]-1H-pyrrol-3-yl}propansäure;  3-{2-({3-(2-Carboxyethyl)-4-methyl-5-[(Z)-(3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-1H-pyrrol-2-yl}methyl)-4-methyl-5-[(Z)-(4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-1H-pyrrol-3-yl}propanoic acid;  Acide 3-{2-({3-(2-carboxyéthyl)-5-[(Z)-(3-éthènyl-4-méthyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidène)méthyl]-4-méthyl-1H-pyrrol-2-yl}méthyl)-5-[(Z)-(4-éthènyl-3-méthyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidène)méthyl]-4-méthyl-1H-pyrrol-3-yl}propanoïque;  Bilirubin IXa;  Bilirubin: 21H-Biline-8,12-dipropanoicacid,2,17-diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-,;  Cholerythrin;  1,10,19,22,23,24-hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-Biline-8,12-dipropionate;  2,17-diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-Biline-8,12-dipropanoate;  3-(2-((3-(2-carboxyethyl)-4-methyl-5-((3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-2-yl)methyl)-4-methyl-5-((4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-3-yl)propanoate;  3-(2-((3-(2-Carboxyethyl)-4-methyl-5-[(Z)-(3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-1H-pyrrol-2-yl)methyl)-4-methyl-5-[(Z)-(4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene;  3-[2-[[3-(2-carboxyethyl)-5-[(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoate;  3-[2-[[3-(2-carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoate;  1,10,19,22,23,24-hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinylbiline-8,12-dipropionic acid;  2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-biline-8,12-dipropanoic acid;  2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-1,10,19,22,23,24-hexahydro-21H-biline-8,12-dipropanoic acid;  3-(2-((3-(2-Carboxyethyl)-4-methyl-5-((3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-2-yl)methyl)-4-methyl-5-((4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid;  3-(2-{[3-(2-carboxyethyl)-5-[(4-ethenyl-3-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl}-5-[(3-ethenyl-4-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl)propanoic acid;  3-(2-{[3-(2-carboxyethyl)-5-{[(2Z)-3-ethenyl-4-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-ylidene]methyl}-4-methyl-1H-pyrrol-2-yl]methyl}-5-{[(2Z)-4-ethenyl-3-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-ylidene]methyl}-4-methyl-1H-pyrrol-3-yl)propanoic acid;  3-(2-{[3-(2-carboxyethyl)-5-{[(2Z)-4-ethenyl-3-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-ylidene]methyl}-4-methyl-1H-pyrrol-2-yl]methyl}-5-{[(2Z)-3-ethenyl-4-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-ylidene]me;  3-[2-[[3-(2-Carboxyethyl)-5-[(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid;  3-[2-[[3-(2-carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid;  3-[2-[[3-(2-Carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid;  3-{2-({3-(2-carboxyethyl)-4-methyl-5-[(Z)-(3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-1H-pyrrol-2-yl}methyl)-4-methyl-5-[(Z)-(4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene;  3-{2-({3-(2-carboxyethyl)-4-methyl-5-[(Z)(3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-1H-pyrrol-2-yl}methyl)-4-methyl-5-[(Z)(4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-1H-pyrrol-3-yl}propanoic acid;  4E,15Z-Bilirubin IXa;  8,12-bis(2-carboxyethyl)-2,7,13,17-tetramethyl-3,18-divinylbiladiene-ac-1,19(21H,24H)-dione;  Biline-8,12-dipropionic acid, 1,10,19,22,23,24-hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-;  Bilirubin (α);  bilirubin IXalpha;  Bilirubin IXα; Bilirubin IX-α;  bilirubin(Z,Z);  bilirubin, [10-3h]-;  bilirubin, 99%;  bilirubin,98%;  BILIVERDINE IX α;  c33h36n4o6;  hematodin;  HEMATOIDIN;  Hemetoidin;  Principal bile pigment;  Pseudoginsenoside-F11;  胆红素

Field of Interest: Medicine, Liver Disease, Diagnostic Reagent

Background: Frontier Specialty Chemicals provides high purity bilirubin for your application. Bilirubin is a linear tetrapyrrole formed from heme breakdown during normal red blood cell recycling.^1-2 It is excreted in the urine and bile and laboratory tests to detect it are usedto diagnose liver dysfunction and neonatal jaundice.^3-4

If you are looking for Bilirubin Conjugate, please see our listing for Bilirubin Conjugate B850.

References:
1.) Boiadjiev, Stefan E.; Person, Richard V.; Puzicha, Gisbert; Knobler, Carolyn; Maverick,Emily; Trueblood, Kenneth N.; Lightner, David A., Absolute configuration of bilirubin conformational enantiomers, Journal of the American Chemical Society (1992), 114(26), 10123-33.

2.) Kamisako, Toshinori; Kobayashi, Yoshinao; Takeuchi, Keisuke; Ishihara, Tomoaki; Higuchi, Kunihiro; Tanaka, Yuji; Gabazza, Esteban C.; Adachi, Yukihiko, Recent advances in bilirubin metabolism research: the molecular mechanism of hepatocyte bilirubin transport and its clinical relevance, Journal of Gastroenterology (2000), 35(9), 659-664.

3.) Iimuro, Yuji; Nishiura, Teruhiro; Hellerbrand, Claus; Behrns, Kevin E.; Schoonhoven, Robert; Grisham, Joe W.; Brenner, David A., NFκB prevents apoptosis and liver dysfunction during liver regeneration, Journal of Clinical Investigation (1998), 101(4), 802-811.

4.) Drummond, George S.; Kappas, Attallah, Prevention of neonatal hyperbilirubinemia by
tin protoporphyrin IX, a potent competitive inhibitor of heme oxidation, Proceedings of the National Academy of Sciences of the United States of America (1981), 78(10), 6466-70.